Quan điểm mới về các tác nhân kháng khuẩn: Điều trị COVID-19 bằng Remdesivir
Tóm tắt
Từ khóa
#Remdesivir; COVID-19; điều trị; virus corona; RNA; tiền lâm sàng; ức chếTài liệu tham khảo
World Health Organization. 2020. WHO coronavirus Disease (COVID-19) dashboard. https://covid19.who.int/. Accessed 29 October 2020.
U.S. Food and Drug Administration. 1 May 2020. Coronavirus (COVID-19) update: FDA issues Emergency Use Authorization for potential COVID-19 treatment. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-emergency-use-authorization-potential-covid-19-treatment. Accessed 26 June 2020.
European Medicines Agency. 25 June 2020. First COVID-19 treatment recommended for EU authorization. https://www.ema.europa.eu/en/news/first-covid-19-treatment-recommended-eu-authorisation. Accessed 20 August 2020.
Gilead. 3 July 2020. European Commission grants conditional marketing authorization for Gilead’s Veklury (remdesivir) for the treatment of COVID-19. https://www.gilead.com/news-and-press/press-room/press-releases/2020/7/european-commission-grants-conditional-marketing-authorization-for-gileads-veklury-remdesivir-for-the-treatment-of-covid19#:~:text=In%20recognition%20of%20the%20current Emirates%20and%20the%20European%20Union. Accessed 20 August 2020.
U.S. Food and Drug Administration. 2020. Veklury (remdesivir) EUA letter of approval. Reissued 22 October 2020. https://www.fda.gov/media/137564/download. Accessed 22 October 2020.
European Medicines Agency. 2020. Summary on compassionate use—remdesicir Gilead. https://www.ema.europa.eu/en/documents/other/summary-compassionate-use-remdesivir-gilead_en.pdf. Accessed 13 June 2020.
World Health Organization. 2018. Deliberations on design options for randomized controlled clinical trials to assess the safety and efficacy of investigational therapeutics for the treatment of patients with Ebola virus disease. https://www.who.int/ebola/drc-2018/summaries-of-evidence-experimental-therapeutics.pdf?ua=1. Accessed 15 June 2020.
U.S. Food and Drug Administration. July 2020. Fact sheet for health care providers Emergency Use Authorization (EUA) of Veklury (remdesivir). https://www.fda.gov/media/137566/download. Accessed 28 October 2020.
NIH. 2020. COVID-19 treatment guidelines. https://www.covid19treatmentguidelines.nih.gov/antiviral-therapy/remdesivir/. Accessed 21 September 2020.
World Health Organization. 18 February 2020. COVID-19 therapeutic trial synopsis. https://www.who.int/publications-detail/covid-19-therapeutic-trial-synopsis. Accessed 13 June 2020.
Pan H Peto R Karim QA Alejandria M Henao-Restrepo AM Hernández García C Kieny MP Malekzadeh R Murthy S Preziosi MP Reddy S Roses Periago M Sathiyamoorthy V Røttingen JA Swaminathan S. 2020. Repurposed antiviral drugs for COVID-19–interim WHO SOLIDARITY trial results. medRxiv Preprint doi:10.1101/2020.10.15.20209817.
World Health Organization. 2020. An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of care. https://www.who.int/publications/m/item/an-international-randomised-trial-of-additional-treatments-for-covid-19-in-hospitalised-patients-who-are-all-receiving-the-local-standard-of-care. Accessed 21 October 2020.
Cochrane Methods. 2020. RoB 2: a revised Cochrane risk-of-bias tool for randomized trials. https://methods.cochrane.org/bias/resources/rob-2-revised-cochrane-risk-bias-tool-randomized-trials. Accessed 21 October 2020.
World Health Organization. 2020. Global COVID-19 clinical platform: rapid core case report form (CRF). https://www.who.int/publications/i/item/WHO-2019-nCoV-Clinical_CRF-2020.4. Accessed 21 October 2020.